CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 46 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,125 | -25.1% | 250,000 | 0.0% | 0.00% | – |
| Q2 2023 | $384,500 | -37.4% | 250,000 | -50.0% | 0.00% | – |
| Q1 2023 | $614,250 | +116.9% | 500,000 | +100.0% | 0.00% | – |
| Q4 2022 | $283,250 | +3.4% | 250,000 | 0.0% | 0.00% | – |
| Q3 2022 | $274,000 | -93.8% | 250,000 | -93.2% | 0.00% | – |
| Q2 2022 | $4,415,000 | -24.5% | 3,655,000 | +7.3% | 0.00% | – |
| Q1 2022 | $5,851,000 | +3.4% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2021 | $5,661,000 | +7.6% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,263,000 | -4.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,486,000 | +3.1% | 3,405,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,322,000 | +11.8% | 3,405,000 | 0.0% | 0.00% | – |
| Q4 2020 | $4,760,000 | +24.9% | 3,405,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,812,000 | +7.0% | 3,405,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,564,000 | -39.9% | 3,405,000 | -46.8% | 0.00% | -100.0% |
| Q1 2020 | $5,929,000 | – | 6,405,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
| III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
| SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
| MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
| Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |